Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTR | Q99707 | 1/20 | 0.43 |
| ▸ | SCN1A | P35498 | 13/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 13/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 13/20 | 0.41 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6186340 | 1.00 | MTR (0.43) | MTRSCN1ASCN5ASCN9APARP2 | |
| SCHEMBL6190749 | 1.00 | MTR (0.43) | MTRSCN1ASCN5ASCN9APARP2 | |
| SCHEMBL6600299 | 0.86 | MTR (0.50) | MTRSCN1ASCN5ASCN9APARP2 | |
| SCHEMBL6187741 | 0.84 | MTR (0.48) | MTRSCN1ASCN5ASCN9APARP2 | |
| SCHEMBL4208514 | 0.84 | MTR (0.48) | MTRSCN1ASCN5ASCN9APARP2 | |
| SCHEMBL6607670 | 0.83 | MTR (0.47) | MTRSCN1ASCN5ASCN9APARP2 | |
| SCHEMBL6187121 | 0.82 | MTR (0.50) | MTRSCN1ASCN5ASCN9APARP2 | |
| SCHEMBL8932764 | 0.81 | PARP2 (0.41) | MTRSCN1ASCN5ASCN9APARP2 | |
| SCHEMBL8207052 | 0.80 | SCN1A (0.43) | MTRSCN1ASCN5ASCN9A | |
| SCHEMBL8207058 | 0.80 | SCN1A (0.43) | MTRSCN1ASCN5ASCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6034098-A | ATHEROSCLEROSIS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-03-07 | — | — | US | claimed |
| EP-0886637-A4 | — | — | 1998-12-30 | — | — | EP | claimed |
| EP-0886637-A1 | INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-12-30 | — | — | EP | claimed |
| WO-1996026205-A1 | INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-08-29 | — | — | WO | claimed |
| EP-0886637-B9 | INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD | BRISTOL MYERS SQUIBB CO (US) | 2005-05-04 | — | — | EP | disclosed |
| EP-0886637-B1 | INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD | BRISTOL MYERS SQUIBB CO (US) | 2004-12-01 | — | — | EP | disclosed |
| US-6066650-A | USEFUL FOR LOWERING SERUM LIPIDS AND TREATING ATHEROSCLEROSIS AND RELATED DISEASES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-05-23 | — | — | US | disclosed |
| US-6034098-A | ATHEROSCLEROSIS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-03-07 | — | — | US | disclosed |
| EP-0886637-A1 | INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-12-30 | — | — | EP | disclosed |
| EP-0886637-A4 | — | — | 1998-12-30 | — | — | EP | disclosed |
| WO-1996026205-A1 | INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-08-29 | — | — | WO | disclosed |